FIELD: biochemical engineering.
SUBSTANCE: set is usable for testing antibodies in tumors, like radioactively labeled anti-CD20-conjugates. The conjugates are used for treating and diagnosing B-cell lymphoma tumors. All reagents are sterile.
EFFECT: wide range of functional applications.
103 cl, 38 dwg, 46 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATMENT, ANTIBODIES, HYBRIDOMA | 1993 |
|
RU2139731C1 |
| NOVEL RADIOIMMUNOCONJUGATES AND USE THEREOF | 2011 |
|
RU2664475C1 |
| METHOD FOR UPREGULATING ANTIGEN EXPRESSION | 2014 |
|
RU2681953C2 |
| NOVEL RADIOIMMUNOCONJUGATES AND THEIR APPLICATIONS | 2011 |
|
RU2560587C9 |
| CHIMERIC THERAPEUTIC ANTI-CD-37 ANTIBODY HH1 | 2012 |
|
RU2658438C2 |
| RADIOACTIVE IMMUNOREAGENT OF THE DIRECTED EFFECT, A COMPOSITION FOR OBTAINING AN IMAGE OF MALIGNANT NEOPLASM IN BODY, A METHOD OF OBTAINING AN IMAGE AND A CHELATING AGENT | 1992 |
|
RU2122431C1 |
| MONOCLONAL ANTI-CD20-ANTIBODY | 2006 |
|
RU2415871C2 |
| TREATMENT OF B-CELLULAR MALIGNANT TUMORS USING ANTI-CD40L ANTIBODIES IN COMBINATION WITH ANTI-CD20 ANTIBODIES AND/OR BY CHEMOTHERAPY AND RADIOTHERAPY | 2000 |
|
RU2305561C2 |
| RADIOACTIVE METAL-LABELLED ANTI-CADHERIN ANTIBODY | 2011 |
|
RU2577125C2 |
| IMMUNOTHERAPY OF MALIGNANT DISEASES OF B-CELLS AND AUTOIMMUNE DISEASES WITH APPLICATION OF CONJUGATE AND NONCONJUGATE ANTIBODIES, COMBINATIONS OF ANTIBODIES AND CONJOINT PROTEINS | 2003 |
|
RU2335297C2 |
